Our latest research and evaluations is published regularly in:
- Medicinewise News
- 15 July 2019
Thyroid disease: challenges in primary care
Thyroid dysfunction is common, but thyroid testing should only be requested after a detailed clinical history and targeted physical examination have suggested thyroid problems.
- 8 July 2019
Vitamin D supplementation in musculoskeletal health: what's new?
Although vitamin D plays a significant role in musculoskeletal health, evidence does not support the use of vitamin D supplementation for healthy people.
- 4 July 2019
Heart health check items added to the MBS
GPs are now funded to conduct heart health assessments annually.
- 29 June 2019
Supporting quality use of referrals
The information provided on an imaging request form has a direct impact on patient care and safety.
- 29 June 2019
Thyroid disorders: test, treat, refer?
Thyroid disorders affect up to 5% of Australians. Find out more about managing this condition.
- 26 February 2019
Can vitamin C help type 2 diabetes?
Could vitamin C help people with type 2 diabetes? A small study suggests it might, but there's more to the story. Find out more.
- 6 February 2019
Are lavender oil capsules effective for anxiety?
Lavender oil capsules (Seremind) are being marketed as an anti-anxiety medicine. What does the evidence show about the effectiveness of this complementary medicine?
Contact our media team
If you are a journalist seeking comment on a story or more information on any of our programs or campaigns please contact the NPS MedicineWise media team
on 02 8217 8667.
For urgent media requests outside of office hours, please call 0419 618 365. If your request is not urgent you can also email an enquiry.
Publications & Programs
Australian Prescriber is an independent peer-reviewed journal that provides critical commentary on drugs and therapeutics for health professionals.
Peak stories have included the top 10 most expensive drugs, eradication of Hepatitis C, drug seeking behaviours in people and more.
RADAR provides health professionals with timely information on new drugs, medical tests and changes to listings on the Pharmaceutical Benefits Scheme and Medicare Benefits Schedule.
Peak stories have included warfarin, campaigns urging doctors to seeing health reps, and treating Hepatitis C.